Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 26Lymphoma 24Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Leukemia 11Neuroblastoma 10Lymphoma, Non-Hodgkin 10Central Nervous System Neoplasms 8Lymphoma, Follicular 6Hodgkin Disease 6Sarcoma 5Retinoblastoma 5Lymphoma, T-Cell, Peripheral 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Mantle-Cell 4Immunoblastic Lymphadenopathy 4Wilms Tumor 3Oligodendroglioma 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large-Cell, Anaplastic 3Kidney Neoplasms 3Burkitt Lymphoma 3Astrocytoma 3Recurrence 2Neuroectodermal Tumors, Primitive, Peripheral 2Neoplasms, Plasma Cell 2Neoplasms 2Multiple Myeloma 2Leukemia, T-Cell 2Leukemia, Biphenotypic, Acute 2Enteropathy-Associated T-Cell Lymphoma 2

Interventions

Etoposide 5pegaspargase 4Dexamethasone 3Methylprednisolone 2Gemcitabine 2Doxorubicin 2sintilimab 1ruxolitinib 1Vincristine 1Th1-Th2 Balance 1Prednisone 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1EPOCH protocol 1Cyclophosphamide 1Cisplatin 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Lymphohistiocytosis, Hemophagocytic × Vincristine × Clear all
NCT01818908 2019-02-15

Trial of DA-EPOCH Regimen for NHL With HLH

The First Affiliated Hospital with Nanjing Medical University

Phase 2 Unknown
50 enrolled
LymphoidMyeloid

Lymphoma, Non-Hodgkin, Lymphohistiocytosis, Hemophagocytic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡